August 18-19, 2021 | Virtual Event
COVID-19 has hit the pharmaceutical industry in the mergers and acquisitions, IP, and due diligence areas within the life science industry. The challenges arise as pharma companies cannot successfully perform their due diligence or close deals virtually, which creates a barrier to deals while there is an increase in the sellers market. However, professionals say that COVID-19 and the production of vaccines grabbed new eyes to the life science space – which is likely to increase investor interest and awareness to the role it plays around the world. Even so, they believe that drug pricing conversations may begin again due to the new healthcare policies of the presidential administration where the US will mainly focus on biopharma investors.
Within new trends emerging the pressure to meet growth expectations are placing added emphasis and challenges with internal pipeline and development challenges are now focused on M&A activities for Life Science Companies. It is imperative for today’s organizations to develop robust M&A capabilities that address the challenges and opportunities of diversification; joint ventures, alliances, and licensing deals, and emerging markets.


Neil Berkley
Neil Berkley
Vice President, Head of Business Development


Anu Daniel
Anu Daniel
Director, Due Diligence


Somjeet Dey
Somjeet Dey
Business Development and Alliance Management


Teresa Faria
Teresa Faria
Senior Director, Alliance Management


Tayseer Ghazzouli
Tayseer Ghazzouli
Senior Director, Head of Alliance Management & IC Support


Kenneth Jaconetty
Kenneth Jaconetty
Senior Director, IP Legal Lead For IP Transactions


Lizabeth Leveille
Lizabeth Leveille
Vice President and Head, BD&L Boston & European Innovation Hubs


Tushar Nuwal
Tushar Nuwal
Vice President, BD&L, Strategy & Alliance Management


Scott Simmons
Scott Simmons
Advisor, External Innovation – Due Diligence



Pharmaceutical, Biotechnology, and Medical Device professionals whose responsibilities include:

Secondary Market

  • Due Diligence
  • Business Development
  • Strategic Alliance/Alliance Management
  • Mergers and Acquisitions
  • Licensing
  • BD&L
  • Digital Partnerships
  • Digital Investments
  • Strategic Alliances/Partnerships Management
  • Intellectual Property and Patent Counsel
  • Search and Evaluation
  • Portfolio Management
  • General Counsel/Corporate Counsel
  • Legal and Regulatory Compliance
  • Legal / Intellectual Property
  • Portfolio / Life Cycle Management
  • Search and Evaluation
  • External Innovation
  • Clinical Operations
  • Regulatory Affairs
  • Compliance
  • Scientific Assessment
  • Transactions
  • Investment Banks
  • Private Equity Firms
  • Venture Capitalists
  • Data Room Providers
  • Due Diligence Consultants
  • Law Firms
  • Clinical Affairs and CRO Partners
  • Regulatory Affairs and Compliance Specialists

Top 5 Reasons to Attend

Reason 1: Maximize marketing efforts in order to increase facilities and IP due diligence
Reason 2: Evaluating new insights on reimbursements, rules and regulations and how it impacts deal-making while mitigating risks
Reason 3: Understanding the role and future of evolving trends such as digital therapeutics
Reason 4: Refine your growth strategies by implementing M&A integration, diligence, and deal sourcing
Reason 5: Evaluating the roadmap for integrating business development and the alliance management life-cycle

Silver Sponsor

Sponsorship Opportunities are Now Available!
If you are interested in sponsorship opportunities please send an email to Shelly Urish at


✔ Virtual Matchmaking: Visit our virtual lobby and connect with fellow attendees using our platform’s matchmaking technology. You can chat, video, and even make a list of the people you want to meet and the knowledge you’re looking to gain through our bespoke 1:1 match-making services

✔ Roundtable Networking throughout the Summit will give you the chance to connect and meet in-depth your fellow attendees as well as our Sponsors and Speakers

✔ The platform we use allows us to make polls, QA, and chat during the sessions.

✔ Virtual Happy Hour: Grab a drink and bring it to your screen to cheers from afar while continuing to chat with and get to know your fellow conference participants.


Pharmaceutical, Biotechnology, and Medical Device Practitioners

Vendors & Solution Providers


Contact Arianne Leclair at to get more information.

Click here to view the cancellation/refund/transfer policy